VASCERN Spotlights: Juergen Grunert

VASCERN Spotlights: Juergen Grunert This month it’s Juergen Grunert, the European Patient Advocacy Group (ePAG) Co-Chair for our Medium-Sized Arteries Working Group (MSA-WG), who is in the VASCERN Spotlight! Read about his most memorable moment as an ePAG representative so far and his hopes for VASCERN and for the ERNs…

Continue reading

Please follow and like us:
onpost_follow 0
New HTAD-WG Collaborative Publication

A new scientific paper entitled Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first degree relatives has been published! This consensus statement is co-authored by several of our HTAD-WG members including Dr Marlies Kempers (Radboud university medical center), Bart Loeys (University Hospital of Antwerp),…

Continue reading

Please follow and like us:
onpost_follow 0
World Health Day 2018

World Health Day was held on April 7th, 2018. This yearly event, founded by the World Health Organization, aims to encourage dialogue about the importance of Universal health coverage (UHC) while pointing out the inequalities to healthcare access that currently exist in the world and even across Europe. Vytenis Andriukaitis, the…

Continue reading

Please follow and like us:
onpost_follow 0
ERNs and eHealth in the Media

Dr. Ana Rath, Director of Orphanet, gave an interview about eHealth and its beneficial use in the European Reference Networks (ERNs) that appeared in the Rare Disease supplement from Mediaplanet UK that was distributed with The Guardian on Rare Disease Day 2018. In this article she talks about how “technology can help the rare disease…

Continue reading

Please follow and like us:
onpost_follow 0
VASCERN Spotlights: Professor Miikka Vikkula

VASCERN Spotlights: Professor Miikka Vikkula This month we interview the Chair of the Vascular Anomalies Working Group (VASCA WG), Professor Miikka Vikkula, a human geneticist from Brussels, Belgium. Prof Vikkula talks about the challenges of working in the rare disease field and the amazing progress that has been made to…

Continue reading

Please follow and like us:
onpost_follow 0
Start of VASCERN’s 2nd Year Activities

Since March, 1st 2018, VASCERN has started its second year of activities under the 5 Year Framework Partnership Agreement (FPA)! This second year (March 2018-February 2019) will be covered by the Specific Grant Agreement (SGA) for Year 2, currently under preparation with CHAFEA (The Consumers, Health, Agriculture and Food Executive…

Continue reading

Please follow and like us:
onpost_follow 0
First Patients Enrolled in the CPMS for VASCERN!

VASCERN is happy to report that we have enrolled out first two patients, one from France and one from the Netherlands, in the Clinical Patient Management System (CPMS). We also just launched our first panel in the CPMS, with more than 10 HCP representatives from 7 countries participating! The CPMS…

Continue reading

Please follow and like us:
onpost_follow 0
EU Consultation on the future EU Research Programme FP9

The European Commission has opened a call for feedback in which research and innovation stakeholders, as well as the general public, can provide their input on the report prepared by Professor Mazzucato regarding the proposal of the next research and innovation EU framework programme. The results of this consultation will be…

Continue reading

Please follow and like us:
onpost_follow 0